000			03007nam a22004335i 4500
001			978-0-387-30410-6
003			DE-He213
005			20250710083946.0
007			cr nn 008mamaa
008			100301s2009 xxu| s |||| 0|eng d
020			_a9780387304106 _a99780387304106
024	7		_a10.1007/978-0-387-30410-6 _2doi
082	0	4	_a612.8 _223
100	1		_aLajtha, Abel. _eeditor.
245	1	0	_aHandbook of Neurochemistry and Molecular Neurobiology _h[recurso electrónico] : _bSchizophrenia / _cedited by Abel Lajtha, Daniel Javitt, Joshua Kantrowitz.
264		1	_aBoston, MA : _bSpringer US : _bImprint: Springer, _c2009.
300			_bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aHippocampus -- Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms -- An overview and current perspective on family studies of schizophrenia -- Synaptic vesicle associated proteins and schizophrenia -- Cortical dopamine in schizophrenia -- G72/g30 in neuropsychiatric disorders -- Cholinergic mechanisms in schizophrenia -- The neurobiology of negative symptoms and the deficit syndrome -- Alterations of neurotransmitter receptors in schizophrenia: Evidence from postmortem studies -- Auditory cortex anatomy and asymmetry in schizophrenia -- Event related potentials (ERPS) in the study of schizophrenia: How pre-clinical ERP studies have contributed to our understanding of schizophrenia -- Neuregulin 1 and schizophrenia -- The role of prefrontal abnormalities in schizophrenia -- Early-stage visual processing deficits in schizophrenia and implications for higher level function -- Magnetic resonance spectroscopy -- Dysbindin-1 and its protein family -- Glutamate and schizophrenia: Phencyclidine, n-methyl-d-aspartate (NMDA) receptors: Etiology and treatment.
520			_aThis volume of the Handbook of Neurochemistry and Molecular Neurobiology focuses on neurochemical aspects of schizophrenia. Chapters cover the full range of schizophrenia symptoms and anatomical pathologies from neurochemical and molecular biology perspectives. Topics include changes in neurotransmitter systems, alteration in receptors, neurotransmitter release, genetic factors, protein alterations, and redox dysregulation.
650		0	_aMEDICINE.
650		0	_aNEUROSCIENCES.
650		0	_aPSYCHOLOGY, CLINICAL.
650	1	4	_aBIOMEDICINE.
650	2	4	_aNEUROSCIENCES.
650	2	4	_aNEUROPSYCHOLOGY.
700	1		_aJavitt, Daniel. _eeditor.
700	1		_aKantrowitz, Joshua. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9780387303659
856	4	0	_uhttp://dx.doi.org/10.1007/978-0-387-30410-6 _zVer el texto completo en las instalaciones del CICY
912			_aZDB-2-SBL
942			_2ddc _cER
999			_c57048 _d57048